Last reviewed · How we verify

NCT05661305: AHC-EHVol

Aswan Heart Centre - Egyptian Healthy Volunteers

Recruiting now Last updated 22 December 2022
What this trial tests

trial testing Whole Genome Sequencing to compare healthy volunteers genome with that of cardiomyopathies patients. in Genetic Predisposition to Disease in 1,000 participants. Currently enrolling.

Timeline
1 January 2019
Primary endpoint
31 December 2025
31 January 2030

Quick facts

Lead sponsorMagdi Yacoub Heart Foundation
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 January 2019
Primary completion31 December 2025
Estimated completion31 January 2030
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Magdi Yacoub Heart Foundation

Who can join

18 and older, any sex, with Genetic Predisposition to Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To define the genotype of a healthy Egyptian cohort as a crucial step in determining the possible clinical implications of mutations detected in patients recruited in the registry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Genetic Predisposition to Disease

Currently open trials in the same condition.

Other Magdi Yacoub Heart Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05661305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing